首页> 外文期刊>Vaccine >BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children
【24h】

BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children

机译:BCG(卡介苗的芽孢杆菌杆菌)疫苗接种可改善巴西学龄儿童对结核杆菌抗原的分枝杆菌抗原的体外IFN-γ应答,从而改善

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberculin skin test (TST) response and cytokine production in finger stab-derived whole blood cultures from 136 BCG scar-positive school-age children were evaluated before and after BCG revaccination. Fifty-four percent of the children increased in vitro production of IFN-gamma after revaccination, and this increase was highly significant for previously unresponsive children (P < 0.0001). No correlation was found between TST response and cytokine production. Our data suggest that the in vitro IFN-gamma response to mycobacterial antigens can be boosted by BCG revaccination and may contribute to the search of correlates of protection to be used for the evaluation of new mycobacterial vaccines.
机译:在BCG疫苗接种前后,评估了136名BCG瘢痕阳性学龄儿童手指刺全血培养物中的结核菌素皮肤试验(TST)反应和细胞因子生成。再次接种后,有54%的儿童增加了IFN-γ的体外产生,而这种增加对于以前无反应的儿童而言非常显着(P <0.0001)。在TST反应和细胞因子产生之间未发现相关性。我们的数据表明,BCG疫苗接种可以增强对分枝杆菌抗原的体外IFN-γ反应,并可能有助于寻找保护性相关性,以用于评估新的分枝杆菌疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号